Using a new technique for closely
studying host blood DNA, the team determined the host origin for three - quarters of these samples, showing that the flies had fed on over 20 different species ranging from elephants and hippopotamuses to reptiles and birds.
Not exact matches
And his group has applied for funding to run lab
studies to see if the fish
hosting blotchy lesions develop more subtle — and disturbing — symptoms with time, such as a slower swimming speed or changes in
blood - cell counts.
Dr Renate Smallegange, a visiting researcher at the School who worked on the pilot
study, said: «It is exciting that we are the first ones to prove this phenomenon in a biological relevant system of mosquito, parasite and
blood host, and, moreover, in a system affecting millions of people in sub-Saharan Africa.»
Lead author Paul - Yannick Bitome - Essono, from the National Center for Scientific and Technological Research, France, explains: «We thought the tsetse fly might be a good candidate in our
study, as both sexes feed on
blood, they are large and easily trapped, present in large numbers in Central Africa, and are opportunistic feeders with no strong preference for a particular
host animal, so would feed on a large range of wildlife.»
And that could be bad if what happens in laboratory animals also happens in people, because
studies in rodents show that BPA can trigger a
host of harmful changes, from reproductive havoc to impaired
blood - sugar control and obesity (SN: 9/29/07, p. 202).
In a comprehensive and complex molecular
study of
blood samples from Ebola patients in Sierra Leone, published in Cell
Host and Microbe, a scientific team led by the University of Wisconsin - Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts.
A
study of the way malaria parasites behave when they live in human red
blood cells has revealed that they can rapidly change the proteins on the surface of their
host cells during the course of a single infection in order to hide from the immune system.
A new test may reveal which patients will respond to treatment for graft versus
host disease (GVHD), an often life - threatening complication of stem cell transplants (SCT) used to treat leukemia and other
blood disorders, according to a
study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the journal Lancet Haematology and in print in the January issue.
Host: Dr. Tim Murphy Speaker: Dr. Leonard Khiroug, Neurotar Title: In vivo two - photon imaging of fluorescently - labeled macromolecule penetration through
blood - brain barrier: applications in Pharma preclinical
studies
Goyal RK, Lin Y, Schultz KR, Ferrell RE, Kim Y, Fairfull L, Livote E, Yanik G, Atlas M. Tumor necrosis factor - alpha gene polymorphisms are associated with severity of acute graft - versus -
host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric
Blood and Marrow Transplant Consortium
study.
Studies have shown that oleuropein provides a
host of health benefits, including modulating
blood sugar, regulating heartbeat, reducing the risk of cancer, fighting inflammation and boosting the immune system.
The
study found that while peripheral
blood stem cells may reduce the risk of graft failure, bone marrow may cut the chances of developing chronic graft - versus -
host disease (GVHD), a complication that is frequently debilitating.